keyword
https://read.qxmd.com/read/38646223/post-mastectomy-pain-syndrome-a-review-article-and-emerging-treatment-modalities
#21
REVIEW
Jay D Shah, Kennedy Kirkpatrick, Krishna Shah
Post-mastectomy pain syndrome (PMPS) is a syndrome broadly applied to the development of chronic pain after surgical breast intervention (i.e., lumpectomy and mastectomy). The incidence of PMPS is likely underreported, and this has contributed to a paucity of high-level evidence related to the treatment of the aforementioned condition. A drive to reduce the burden of opioid use has led to pain management physicians trialing a variety of strategies to help patients manage PMPS. This review discusses the latest evidence behind treatment options for PMPS, exploring medications as well as interventional techniques (e...
March 2024: Curēus
https://read.qxmd.com/read/38646222/in-vitro-exploration-of-dark-cytotoxicity-of-anthocyanin-curcumin-combination-a-herbal-photosensitizer
#22
JOURNAL ARTICLE
Dhanya M, Umamaheswari T N, Rajalakshmanan Eswaramoorthy
BACKGROUND: Photodynamic therapy can be used to treat a variety of lesions noninvasively, including oral cancer. High-power laser therapy has also been used to treat oral squamous cell carcinomas. The two main components of photodynamic treatment are the photosensitizer and the light source. Herbal formulations of photosensitizers are used to mask the disadvantages of other photosensitizers. METHODOLOGY: A methanol-diluted 25 grams of Punica granatum was used to create an anthocyanin extract using the flash evaporation method...
March 2024: Curēus
https://read.qxmd.com/read/38645412/link-a-unveiling-its-functional-role-and-clinical-significance-in-human-tumors
#23
REVIEW
Bing Liao, Jialing Wang, Yilin Xie, Hongliang Luo, Jun Min
LINK-A, also recognized as LINC01139, has emerged as a key oncological lncRNA in cancer. LINK-A is upregulated in solid and liquid tumor samples, including breast cancer, ovarian cancer, glioma, non-small-cell lung cancer, and mantle cell lymphoma. Notably, LINK-A is involved in regulating critical cancer-related pathways, such as AKT and HIF1α signaling, and is implicated in a range of oncogenic activities, including cell proliferation, apoptosis, epithelial-mesenchymal transition (EMT), cell invasion and migration, and glycolysis reprogramming...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38644851/melatonin-inhibits-tongue-squamous-cell-carcinoma-interplay-of-er-stress-induced-apoptosis-and-autophagy-with-cell-migration
#24
JOURNAL ARTICLE
Huimin Liu, Ye Zheng, Shaoning Kan, Ming Hao, Huan Jiang, Shuangji Li, Rong Li, Yinyu Wang, Dongxu Wang, Weiwei Liu
Tongue squamous cell carcinoma (TSCC) occupies a high proportion of oral squamous cell carcinoma. TSCC features high lymph node metastasis rates and chemotherapy resistance with a poor prognosis. Therefore, an effective therapy strategy is needed to improve patient prognosis. Melatonin (MT) is a natural indole compound shown to have anti-tumor effects in several cancers. This study focused on the role and mechanism of MT in TSCC cells. The results of the study suggest that MT could inhibit cell proliferation in CRL-1623 cells...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38644711/alpha-lipoic-acid-an-antioxidant-with-anti-aging-properties-for-disease-therapy
#25
JOURNAL ARTICLE
Mariia Shanaida, Roman Lysiuk, Olha Mykhailenko, Nataliia Hudz, Abdullateef Abdulsalam, Tetiana Gontova, Oleksandra Oleshchuk, Yana Ivankiv, Volodymyr Shanaida, Dmytro Lytkin, Geir Bjørklund
The anti-aging effects of alpha-lipoic acid (αLA), a natural antioxidant synthesized in human tissues, have attracted a growing interest in recent years. αLA is a short- -chain sulfur-containing fatty acid occurring in the mitochondria of all kinds of eukaryotic cells. Both the oxidized disulfide of αLA and its reduced form (dihydrolipoic acid, DHLA) exhibit prominent antioxidant function. The amount of αLA inside the human body gradually decreases with age resulting in various health disorders...
April 19, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38644367/salvage-prostate-intensity-modulated-radiation-therapy-after-cryotherapy-failure
#26
JOURNAL ARTICLE
Tanguy Perennec, Maximilien Rogé, Jean-François Hetet, Philippe Colls, Valentine Guimas, Emmanuel Rio, Loïg Vaugier, Stéphane Supiot
Cryotherapy is an ablative therapy that can be used to treat localized prostate cancer. In case of recurrence, treatment options are not well-defined, and their outcomes are unknown. We therefore collected all patients treated with radiotherapy after cryotherapy for prostate cancer recurrence in Nantes (France) between 2012 and 2019. We identified ten patients. After a median follow-up of 5 years, two patients presented late grade 3 toxicities; one patient presented a grade 3 rectal hemorrhage, and one had a grade 3 hematuria...
April 21, 2024: Scientific Reports
https://read.qxmd.com/read/38644364/tumor-growth-arrest-effect-of-tetrahydroquinazoline-derivative-human-topoisomerase-ii-alpha-inhibitor-in-hpv-negative-head-and-neck-squamous-cell-carcinoma
#27
JOURNAL ARTICLE
Patrizia Sarogni, Nicoletta Brindani, Agata Zamborlin, Alessandra Gonnelli, Michele Menicagli, Ana Katrina Mapanao, Federico Munafò, Marco De Vivo, Valerio Voliani
Oral malignancies continue to have severe morbidity with less than 50% long-term survival despite the advancement in the available therapies. There is a persisting demand for new approaches to establish more efficient strategies for their treatment. In this regard, the human topoisomerase II (topoII) enzyme is a validated chemotherapeutics target, as topoII regulates vital cellular processes such as DNA replication, transcription, recombination, and chromosome segregation in cells. TopoII inhibitors are currently used to treat some neoplasms such as breast and small cells lung carcinomas...
April 21, 2024: Scientific Reports
https://read.qxmd.com/read/38643837/e2f1-regulated-usp5-contributes-to-the-tumorigenic-capacity-of-glioma-stem-cells-through-the-maintenance-of-oct4-stability
#28
JOURNAL ARTICLE
Xiao Jiang, Hongtao You, Yixuan Niu, Yudan Ding, Zhengxin Chen, Huibo Wang, Yuan Xu, Peng Zhou, Li Wei, Danni Deng, Lian Xue, Ya Peng, Yilin Yang, Ligang Fan, Naiyuan Shao
Mesenchymal glioma stem cells (MES GSCs) are a subpopulation of cells in glioblastoma (GBM) that contribute to a worse prognosis owing to their highly aggressive nature and resistance to radiation therapy. Here, OCT4 is characterized as a criticial factor in sustaining the stemness phenotype of MES GSC. We find that OCT4 is expressed intensively in MES GSC and is intimately associated with poor prognosis, moreover, OCT4 depletion leads to diminished invasive capacity and impairment of the stem phenotype in MES GSC...
April 19, 2024: Cancer Letters
https://read.qxmd.com/read/38643306/interaction-of-olive-oil-based-propolis-and-caffeic-acid-phenethyl-ester-with-methylprednisolone-used-in-the-treatment-of-human-acute-myeloid-leukemia
#29
JOURNAL ARTICLE
Hamide Dogan, A Ata Ozcimen, Sibel Silici
BACKGROUND: Methylprednisolone (MP) is a pharmaceutical agent employed in the management of Leukemia, which is a systemic malignancy that arises from abnormalities in the hematological system. Numerous investigations in the field of cancer research have directed their attention towards propolis, a natural substance with significant potential as a treatment-supportive agent. Its utilization aims to mitigate the potential adverse effects associated with chemotherapy medications. The objective of this study was to examine the impact of olive oil-based propolis (OEP) and caffeic acid phenethyl ester (CAPE) on the treatment of acute myeloid leukemia, as well as to determine if they exhibit a synergistic effect when combined with the therapeutic support product methylprednisolone...
April 20, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38643278/bispecific-car-t-cell-therapy-targeting-bcma-and-cd19-in-relapsed-refractory-multiple-myeloma-a-phase-i-ii-trial
#30
JOURNAL ARTICLE
Ming Shi, Jiaojiao Wang, Hongming Huang, Dan Liu, Hai Cheng, Xu Wang, Wei Chen, Zhiling Yan, Wei Sang, Kunming Qi, Depeng Li, Feng Zhu, Zhenyu Li, Jianlin Qiao, Qingyun Wu, Lingyu Zeng, Xiaoming Fei, Weiying Gu, Yuqing Miao, Kailin Xu, Junnian Zheng, Jiang Cao
Despite the high therapeutic response achieved with B-cell maturation antigen (BCMA)-specific chimeric antigen receptor (CAR) T-cell therapy in relapsed and refractory multiple myeloma (R/R MM), primary resistance and relapse exist with single-target immunotherapy. Here, we design bispecific BC19 CAR T cells targeting BCMA/CD19 and evaluate antimyeloma activity in vitro and in vivo. Preclinical results indicate that BC19 CAR specifically recognize target antigens, and BC19 CAR T cells mediate selective killing of BCMA or CD19-positive cancer cells...
April 20, 2024: Nature Communications
https://read.qxmd.com/read/38643245/increased-prevalence-but-decreased-survival-of-nonviral-hepatocellular-carcinoma-compared-to-viral-hepatocellular-carcinoma-in-recent-ten-years
#31
JOURNAL ARTICLE
Ting-Chun Chen, Shun-Wen Hsiao, Yang-Yuan Chen, Hsu-Heng Yen, Wei-Wen Su, Yu-Chun Hsu, Siou-Ping Huang, Pei-Yuan Su
Due to the comprehensive hepatitis B virus vaccination program in Taiwan since 1986, the development of antiviral therapy for chronic hepatitis B and chronic hepatitis C infection and covered by National health insurance. Besides, the increased prevalence of nonalcoholic fatty liver disease (NAFLD) and currently, approved therapy for NAFLD remain developing. The etiology of liver-related diseases such as cirrhosis and hepatocellular carcinoma required reinterpretation. This study aimed to analyze the incidence and outcome of hepatocellular carcinoma (HCC) due to viral (hepatitis B and hepatitis C) infection compared to that of nonviral etiology...
April 20, 2024: Scientific Reports
https://read.qxmd.com/read/38642633/the-nucleolus-coordinating-stress-response-and-genomic-stability
#32
REVIEW
Katiuska González-Arzola
The perception that the nucleoli are merely the organelles where ribosome biogenesis occurs is challenged. Only around 30 % of nucleolar proteins are solely involved in producing ribosomes. Instead, the nucleolus plays a critical role in controlling protein trafficking during stress and, according to its dynamic nature, undergoes continuous protein exchange with nucleoplasm under various cellular stressors. Hence, the concept of nucleolar stress has evolved as cellular insults that disrupt the structure and function of the nucleolus...
April 18, 2024: Biochimica et Biophysica Acta. Gene Regulatory Mechanisms
https://read.qxmd.com/read/38642413/targeting-cd8-t-cells-with-natural-products-for-tumor-therapy-revealing-insights-into-the-mechanisms
#33
REVIEW
Yuke Wang, Yan Zeng, Wenyong Yang, Xiuxuan Wang, Jingwen Jiang
BACKGROUND: Despite significant advances in cancer immunotherapy over the past decades, such as T cell-engaging chimeric antigen receptor (CAR)-T cell therapy and immune checkpoint blockade (ICB), therapeutic failure resulting from various factors remains prevalent. Therefore, developing combinational immunotherapeutic strategies is of great significance for improving the clinical outcome of cancer immunotherapy. Natural products are substances that naturally exist in various living organisms with multiple pharmacological or biological activities, and some of them have been found to have anti-tumor potential...
April 8, 2024: Phytomedicine
https://read.qxmd.com/read/38641734/single-cell-multiomic-dissection-of-response-and-resistance-to-chimeric-antigen-receptor-t-cells-against-bcma-in-relapsed-multiple-myeloma
#34
JOURNAL ARTICLE
Michael Rade, Nora Grieb, Ronald Weiss, Jaren Sia, Luise Fischer, Patrick Born, Andreas Boldt, Stephan Fricke, Paul Franz, Jonathan Scolnick, Lakshmi Venkatraman, Stacy Xu, Christina Kloetzer, Simone Heyn, Anne Sophie Kubasch, Ronny Baber, Song Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Birthe Schetschorke, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Ulrike Köhl, Uwe Platzbecker, Kristin Reiche, Vladan Vucinic, Maximilian Merz
Markers that predict response and resistance to chimeric antigen receptor (CAR) T cells in relapsed/refractory multiple myeloma are currently missing. We subjected mononuclear cells isolated from peripheral blood and bone marrow before and after the application of approved B cell maturation antigen-directed CAR T cells to single-cell multiomic analyses to identify markers associated with resistance and early relapse. Differences between responders and nonresponders were identified at the time of leukapheresis...
April 19, 2024: Nature Cancer
https://read.qxmd.com/read/38641673/identification-of-ct-radiomic-features-robust-to-acquisition-and-segmentation-variations-for-improved-prediction-of-radiotherapy-treated-lung-cancer-patient-recurrence
#35
JOURNAL ARTICLE
Thomas Louis, François Lucia, François Cousin, Carole Mievis, Nicolas Jansen, Bernard Duysinx, Romain Le Pennec, Dimitris Visvikis, Malik Nebbache, Martin Rehn, Mohamed Hamya, Margaux Geier, Pierre-Yves Salaun, Ulrike Schick, Mathieu Hatt, Philippe Coucke, Pierre Lovinfosse, Roland Hustinx
The primary objective of the present study was to identify a subset of radiomic features extracted from primary tumor imaged by computed tomography of early-stage non-small cell lung cancer patients, which remain unaffected by variations in segmentation quality and in computed tomography image acquisition protocol. The robustness of these features to segmentation variations was assessed by analyzing the correlation of feature values extracted from lesion volumes delineated by two annotators. The robustness to variations in acquisition protocol was evaluated by examining the correlation of features extracted from high-dose and low-dose computed tomography scans, both of which were acquired for each patient as part of the stereotactic body radiotherapy planning process...
April 19, 2024: Scientific Reports
https://read.qxmd.com/read/38641651/multiparametric-mri-for-characterization-of-the-tumour-microenvironment
#36
REVIEW
Emily Hoffmann, Max Masthoff, Wolfgang G Kunz, Max Seidensticker, Stefanie Bobe, Mirjam Gerwing, Wolfgang E Berdel, Christoph Schliemann, Cornelius Faber, Moritz Wildgruber
Our understanding of tumour biology has evolved over the past decades and cancer is now viewed as a complex ecosystem with interactions between various cellular and non-cellular components within the tumour microenvironment (TME) at multiple scales. However, morphological imaging remains the mainstay of tumour staging and assessment of response to therapy, and the characterization of the TME with non-invasive imaging has not yet entered routine clinical practice. By combining multiple MRI sequences, each providing different but complementary information about the TME, multiparametric MRI (mpMRI) enables non-invasive assessment of molecular and cellular features within the TME, including their spatial and temporal heterogeneity...
April 19, 2024: Nature Reviews. Clinical Oncology
https://read.qxmd.com/read/38641474/natural-history-and-health-care-burden-of-non-curative-treatment-for-muscle-invasive-bladder-cancer
#37
JOURNAL ARTICLE
Haim Herzberg, Yossi Ventura, Karin Lifshitz, Ziv Savin, Shay Golan, Jack Baniel, Ofer Yossepowitch, Roy Mano
OBJECTIVE: Muscle-invasive bladder cancer is an aggressive disease. Yet, many patients, especially those with advanced age and multiple comorbidities, do not receive treatment with curative intent. We evaluated the disease course and health care burden of these patients. MATERIALS AND METHODS: Bi-center, retrospective analysis of patients diagnosed with muscle-invasive bladder cancer who did not undergo curative-intent treatment (radical cystectomy or trimodal therapy) between 2016 and 2021...
April 18, 2024: Urologic Oncology
https://read.qxmd.com/read/38641421/ina03-a-potent-transferrin-competitive-antibody-drug-conjugate-against-cd71-for-a-safer-acute-leukemia-treatment
#38
JOURNAL ARTICLE
Manuela Bratti, Elisa Stubbs, Sergii Kolodych, Herve Souchet, Lois Kelly, Johanna Merlin, Michelle Marchal, Remy Castellano, Emmanuelle Josselin, Hélène Pasquer, Lina Benajiba, Alexandre Puissant, Oleksandr Koniev, Yves Collette, Coralie Belanger, Olivier Hermine, Renato C Monteiro, Pierre Launay
Innovative strategies to enhance efficacy and overcome drug resistance in hematologic cancers such as antibody-drug conjugates (ADCs) have shifted the paradigm of conventional care by delivering promising outcomes in cancer therapies with a significant reduction in the risk of relapse. The transferrin receptor 1, CD71, known to be overexpressed in malignant cells, is considered a potent anti-tumoral target. Therefore, we have developed an anti-CD71 ADC, INA03, a humanized antibody conjugated to the monomethyl auristatin E (MMAE) through a 3-arylpropiolonitrile-valine-citruline linker...
April 20, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38641182/unveiling-clinical-applications-of-bacterial-extracellular-vesicles-as-natural-nanomaterials-in-disease-diagnosis-and-therapeutics
#39
REVIEW
Chun Liu, Negar Yazdani, Corey S Moran, Carlos Salomon, Chaminda Jayampath Seneviratne, Sašo Ivanovski, Pingping Han
Bacterial extracellular vesicles (BEVs) are naturally occurring bioactive membrane-bound nanoparticles released by both gram-negative and positive bacterial species, exhibiting a multifaceted role in mediating host-microbe interactions across various physiological conditions. Increasing evidence supports BEVs as essential mediators of intercellular exchange, influencing bacterial pathogenicity, disease mechanisms, and modulating the host immune response. However, the extent to which these BEV-mediated actions can be leveraged to predict disease onset, guide treatment strategies, and determine clinical outcomes remains uncertain, particularly in terms of their clinical translation potentials...
April 17, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38641123/hierarchical-cluster-analysis-and-nonlinear-mixed-effects-modelling-for-candidate-biomarker-detection-in-preclinical-models-of-cancer
#40
JOURNAL ARTICLE
David Hodson, Hitesh Mistry, James Yates, Sofia Guzzetti, Michael Davies, Leon Aarons, Kayode Ogungbenro
BACKGROUND: Preclinical models of cancer can be of translational benefit when assessing how different biomarkers are regulated in response to particular treatments. Detection of molecular biomarkers in preclinical models of cancer is difficult due inter-animal variability in responses, combined with limited accessibility of longitudinal data. METHODS: Nonlinear mixed-effects modelling (NLME) was used to analyse tumour growth data based on expected tumour growth rates observed 7 days after initial doses (DD7) of Radiotherapy (RT) and Combination of RT with DNA Damage Response Inhibitors (DDRi)...
April 17, 2024: European Journal of Pharmaceutical Sciences
keyword
keyword
48282
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.